Trial Profile
A phase 1, open-label, single-sequence, cross-over study to evaluate the effect of verapamil on the pharmacokinetics of pasireotide in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Nov 2015
Price :
$35
*
At a glance
- Drugs Pasireotide (Primary) ; Verapamil
- Indications Acromegaly; Cushing syndrome; Gastrointestinal disorders; Neuroendocrine tumours; Pituitary ACTH hypersecretion
- Focus Therapeutic Use
- Sponsors Novartis Pharmaceuticals Corporation
- 30 Nov 2015 New trial record